MFN Partners Management as of June 30, 2019
Portfolio Holdings for MFN Partners Management
MFN Partners Management holds 17 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan SHS | 23.9 | $151M | 900k | 167.43 | |
| Fox Corp Cl A Com (FOXA) | 13.8 | $87M | 2.4M | 36.64 | |
| PG&E Corporation (PCG) | 10.2 | $64M | 2.8M | 22.92 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 8.6 | $54M | 4.9M | 10.94 | |
| Xpo Logistics Inc equity (XPO) | 8.4 | $53M | 914k | 57.81 | |
| Cheniere Energy Com New (LNG) | 8.1 | $51M | 750k | 68.45 | |
| Goldman Sachs (GS) | 5.6 | $36M | 174k | 204.60 | |
| Pioneer Natural Resources (PXD) | 4.9 | $31M | 200k | 153.86 | |
| FGL HLDGS Ord Shs | 4.0 | $25M | 3.0M | 8.40 | |
| Gtt Communications | 3.5 | $22M | 1.3M | 17.60 | |
| Cyclerion Therapeutics | 2.7 | $17M | 1.5M | 11.45 | |
| Liberty Global SHS CL C | 2.6 | $17M | 626k | 26.53 | |
| Takeda Pharmaceutical Sponsored Ads (TAK) | 2.2 | $14M | 785k | 17.70 | |
| Navient Corporation equity (NAVI) | 0.5 | $3.3M | 244k | 13.65 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $3.3M | 1.5M | 2.19 | |
| Evolus (EOLS) | 0.3 | $1.8M | 120k | 14.62 | |
| Revance Therapeutics (RVNC) | 0.1 | $597k | 46k | 12.98 |
